Back to search
FDAFDA · Food and drugs·Recall number D-1413-2020

Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08

Published August 5, 2020 · Recall initiated: July 17, 2020

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
LISINOPRIL
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Product was distributed to OH and may have been further distributed throughout the United States.
UPC
0368001334082
Lot
Lot # Q000232, exp. date 01/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card